MarketXLS

Leading Excel Solution for RIAs, Asset Managers, Financial Analysts, and Individual Investors. Not Financial Advice.

[MarketXLS @MarketXLS]

MRNA -131% op margin and +61% YTD is the post-COVID rebuild trade in one cell. Market is pricing pipeline option value (RSV launched, flu and BMI in late-stage trials) against COVID revenue normalization. Different valuation framework from the income statement.

[MarketXLS @MarketXLS]

ALNY +96% revenue growth and -23.8% YTD is the cleanest multiple-compression-on-growth read in biotech right now. RNAi platform stacking Onpattro/Givlaari/Oxlumo/Amvuttra approvals — fundamentals accelerating, price de-rating. Two different framings of the same revenue line.

[MarketXLS @MarketXLS]

VRTX 38% op margin / -1.4% YTD vs SRPT 49% op margin / -27% YTD is the same fat-margin number priced two different ways. CF monopoly book vs single-product gene-therapy binary read. Op margin is a number; what the market is pricing is the asset durability behind it.

[MarketXLS @MarketXLS]

US biotech at Fri close. Op margin spread: GILD 39% / VRTX 38% / AMGN 34% in the black; MRNA still -131% on revenue rebuild. YTD MRNA +61% → SRPT -27% = 88pts inside one sleeve. Same =OperatingMargin() formula, ten different unit-economics stories.

[MarketXLS @MarketXLS]

Template of the day: Portfolio comparison. Two or more portfolios on one tab — weights, exposures, returns side by side. The advisor view for model vs client, before vs after rebalance, or peer benchmarking. https://t.co/47r2F276mc

[MarketXLS @MarketXLS]

CRWD 36x P/S vs FTNT 15x P/S is the platform-consolidation premium priced in. Market is paying for Falcon's modular cross-sell (identity + cloud + log mgmt) on top of endpoint. Different revenue-quality framings on the same 'subscription revenue' line.

[MarketXLS @MarketXLS]

ZS -40% YTD with revenue still growing 25% is the cleanest multiple-compression read in cyber. Same growth, lower price — guidance cadence and competitive overhang from CRWD identity doing the work. Forward PE compressed from triple-digits to 29x — that's the de-rate.

[MarketXLS @MarketXLS]

GEN 63% op margin is the consumer-cyber subscription math at scale. Norton, Avast, LifeLock — direct-to-consumer auto-renewing subs with negligible incremental delivery cost. The two-platform cohort (consumer vs enterprise) ends up with the widest margin spread inside the sleeve.

[MarketXLS @MarketXLS]

FTNT 31% op margin in cyber isn't a SaaS-platform story — it's the network-appliance hardware-plus-software model. ASIC-accelerated FortiGate boxes shipped at gross margins north of 75%, services and renewals layered on top. Different unit economics from CRWD/NET/ZS pure-cloud.

[MarketXLS @MarketXLS]

US cyber at Thu close. Op margin tells the Stock Health Checkup story: GEN 63% / FTNT 31% / OKTA 7% in the black; CRWD, PANW, NET, ZS, S still scaling at -2% to -29%. YTD spread FTNT +89% → ZS -40% = 129pts inside one sleeve. Formula: =OperatingMargin().

[MarketXLS @MarketXLS]

Template of the day: Stock Health Checkup. EPS growth, revenue/net income trends, margins and valuation ratios — all benchmarked vs industry peers. The single-name diagnostic that pairs with Altman Z, Beneish M, Piotroski F at the portfolio level. https://t.co/OaT99fP3HZ

[MarketXLS @MarketXLS]

FIS 7.9x trail / PYPL 8.0x trail are single-digit-PE payments processors — the cohort's deep-value bucket. F-Score read: profitability still ~16-18% op margins, so the math holds. The discount is on growth trajectory and competitive position, not earnings quality.

[MarketXLS @MarketXLS]

XYZ +5.9% YTD despite -2.6% op margin is the F-Score 'low score, high multiple' divergence. Market pricing Cash App network growth and Bitcoin treasury angle, not current GAAP profitability. Two different valuation frameworks looking at the same income statement.

[MarketXLS @MarketXLS]

V 67% / MA 61% op margins are what F-Score profitability looks like in practice. Two-sided network: fixed cost in switches and licensing, txn volume scales on top. Every incremental swipe drops mostly to op income. That's the quality the score is trying to capture.

[MarketXLS @MarketXLS]

AI stock pickers spit out a number. That's not analysis — that's the output of analysis. The actual work is running Piotroski F, Altman Z, Beneish M against five years of 10-K footnotes. AI helps you read faster. It doesn't replace the math.

[MarketXLS @MarketXLS]

US payments & fintech at Wed close. Op margin spread is the F-Score read: V 67% / MA 61% vs SOFI 18% / FIS 16% / XYZ -2.6%. Networks down 11-19% YTD, processors 15-39%. Only XYZ green (+5.9%). Formula: =OperatingMargin().

[MarketXLS @MarketXLS]

Template of the day: Piotroski F-Score. 9-criteria scorecard for financial strength — profitability, leverage, liquidity, operating efficiency. Score 0-9. Pairs with Altman Z and Beneish M to close the forensic due diligence stack. https://t.co/6kJWavYSYI

[MarketXLS @MarketXLS]

BLK -6.1% YTD vs alt cohort -22% to -30% is the passive/scale resilience tell inside asset management. Fee mix on $11T+ AUM does heavy lifting through cycles; alt-mgr P&L runs on capital activity. Same sector, different beta to the rate/credit cycle.

[MarketXLS @MarketXLS]

OWL 9.14% yield / 10.2x fwd PE is BDC/credit-fund dispersion at the widest. -29.8% YTD reflects net-investment-income pressure as direct-lending spreads compress, not payout impairment. Single-digit fwd PE says market is pricing the income line through.

[MarketXLS @MarketXLS]

BEN +32.3% YTD is the cleanest contrarian print in active management. Western Asset workout largely priced through; question is whether the franchise re-stabilizes flow. 10.5x fwd PE / 4.24% yield reads as durable cash-return profile, not growth re-rating.